Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience

Mijin Kim, Jee Hee Yoon, Jonghwa Ahn, Min Ji Jeon, Hee Kyung Kim, Dong Jun Lim, Ho-Cheol Kang, In Joo Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim

Endocrinol Metab. 2020;35(3):587-594. Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.687

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience

Mijin Kim, Jee Hee Yoon, Jonghwa Ahn, Min Ji Jeon, Hee Kyung Kim, Dong Jun Lim, Ho-Cheol Kang, In Joo Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim

Endocrinology and Metabolism. 2020;35(3):587-594

Link1

Link2 Link3

Vandetanib in advanced hereditary medullary thyroid cancer

Jame Abraham

Community Oncology. 2011;8(8):353-354

Link1 Link2

Role of vandetanib in the management of medullary thyroid cancer

Maryse Brassard, Rondeau

Biologics: Targets and Therapy. 2012;59

Link1

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer

Hari Deshpande, Julie Sosa, Marler

OncoTargets and Therapy. 2011;209

Link1

Vandetanib—a new therapeutic option in advanced medullary thyroid cancer

Linda Koch

Nature Reviews Endocrinology. 2011;8(1):1-1

Link1

Link2 Link3

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer

Viktoria F. Koehler, Pia Adam, Karin Frank-Raue, Friedhelm Raue, Elke Berg, Eva Hoster, Stephanie Allelein, Matthias Schott, Matthias Kroiss, Christine Spitzweg,

Thyroid. 2021;31(3):459-469

Link1 Link2

Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer

Gillian M. Keating, Katherine A. Lyseng-Williamson, James E. Frampton

BioDrugs. 2012;26(6):431-435

Link1

Link2 Link3

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

M. Schott

Yearbook of Endocrinology. 2012;2012:153-155

Link1 Link2

Advanced medullary thyroid cancer: pathophysiology and management